Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
Digital Structuring the unstructured: Deterministic AI and white box... Speed and safety in drug development and discovery represent some of the biggest challenges and opportunities facing life sciences companies today.
Digital Artificial intelligence: The saviour of the pharmaceutical i... There is a lot, and I mean a lot, of discussion right now about the potential for artificial intelligence (AI) to transform the pharmaceutical industry (as, indeed, there is across all indu
Sales & Marketing Sponsored The next frontier: How to use AI-powered analytics for life ... Using spreadsheets for data analysis is totally okay, especially if we are talking about standardised small-to-medium datasets.
Digital Considering current legal risks from the use of AI in the li... The use of artificial intelligence (AI) in the life sciences sector is increasing, and its applications may be transformative.
Digital AI-powered computer vision accelerates innovation Few industries are as important to the wellbeing of people than those that produce the medical devices and drugs that enhance and save lives.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.